Clinical trial Recruiting at 1 site Interventional Ages 25 to 70

Pharmacokinetics of Whole-Grain Corn: What Happens After Eating

Official title: Pharmacokinetic (PK) Study of Phytochemicals in Whole Grains (WGs)- Corn

Run by North Carolina Agriculture & Technical State University · NCT07767162 · Data updated 2026-11-12

This study tests how healthy adults absorb and excrete components from whole-grain corn by giving two types of corn on different days and measuring biomarkers in blood, urine, and feces.

More Healthy Adult Females trials

Quick facts

Study typeInterventional
Ages25 Years to 70 Years
SexAll
Enrollment16 (estimated)
SponsorNorth Carolina Agriculture & Technical State University
Academic / other
Locations1 site (Kannapolis, North Carolina)
StatusRecruiting
StartedAugust 4, 2026
Main results expectedNovember 25, 2026
Study endsDecember 31, 2026
Registry record updatedAugust 24, 2026
Trial IDNCT07767162 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Healthy adults aged 25-70 with BMI 18-30, no food allergies to test foods, English literacy, and willingness to follow dietary restrictions.

Probably not a fit

Individuals with active comorbidities, smokers, or those unable to comply with dietary restrictions may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pharmacokinetic study in healthy adults compares whole-grain corn to refined corn in a randomized crossover design. Participants consume two servings of either grain, with samples collected over 48 hours to map absorption and excretion. Researchers use targeted and untargeted metabolomics to identify biomarkers of corn intake and to build a whole-grain metabolite database. The study includes a 6-day washout between visits to ensure no carryover effects. The goal is to identify corn phytochemicals and metabolites that can serve as objective measures of whole-grain corn intake in Americans.

Why it matters

Potential benefit: Identifying objective biomarkers could improve dietary assessment and understanding of whole-grain corn exposure.

How similar studies have gone: Previous pharmacokinetic and metabolomics studies have successfully identified dietary biomarkers, supporting feasibility for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 25-70 years
* Body mass index (BMI) between 18 and 30 kg/m²
* Able to read, speak, and understand English
* No known allergy or intolerance to the test foods
* Normal blood and urine biochemical parameters
* No antibiotic use within the past 6 months
* Willing and able to comply with all study procedures, including dietary restrictions throughout the study period
* No medical conditions or lifestyle factors that, in the opinion of the investigators, would interfere with the study objectives

Exclusion Criteria:

* Active disease, including gout, heart disease, peripheral vascular disease, kidney disease, liver disease, cancer, diabetes, gastrointestinal disorders, or endocrine disorders that may interfere with the study
* Current smoker or use of tobacco products
* Unwilling or unable to comply with the required dietary restrictions during the study period

Where it's running

  • Clinical Research Core (CRC)
    Kannapolis, North Carolina, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.